Revelation Biosciences (REVB) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-20.64
-14.66
-8.69
-2.71

Details

Expected EPS
-2.71
Actual EPS
-2.71
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Revelation Biosciences⁩ (⁦REVB⁩) has reported earnings of ⁦-2.71⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts